When was Fibroblast founded?

Fibroblast was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Fibroblast located?

Fibroblast is headquartered in Chicago, United States.

How many employees does Fibroblast have?

As of Sep 30, 2026, the latest employee count at Fibroblast is 2.

Is Fibroblast a funded company?

Fibroblast is a funded company, having raised a total of $3.23M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 15, 2012.

When was the latest funding round of Fibroblast?

Fibroblast's latest funding was a $***** Seed round on Jan 15, 2020, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $6.71B in funding in 2026 to date.

Where does Fibroblast rank among its competitors?

Fibroblast ranks 39th amongst 115 active competitors, of which 11 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was MiResource, which secured $1.15M in Jan, 2025.

Who are the top competitors of Fibroblast?

Fibroblast's top competitors include MiResource, eHealth Technologies and RubiconMD. Among them, MiResource secured the most recent funding round in January, 2025.

Fibroblast - 2026 Company Profile, Team, Funding & Competitors

Fibroblast is an acqui-hired company based in Chicago (United States), founded in 2011 by Andrew Albert and Scott Vold. It operates as a SaaS based referral management system. Fibroblast has raised $3.23M in funding from Excelerate Labs. The company has 115 active competitors, including 11 funded and 8 that have exited. Its top competitors include companies like MiResource, eHealth Technologies and RubiconMD.

Company Details

Fibroblast is a referral management platform that automates the patient referral process and offers providers with tools needed to actively manage referrals. The company claims its solution prevents patient leakage, increases revenues for fee-for-service organizations and lowers risks for accountable care organizations.

Website: fibroblast.com
Social

Key Metrics

Founded Year

2011

Location

Chicago, United States

Stage

Acqui-Hired

Total Funding

$3.23M in 4 rounds

Latest Funding Round

Seed, Jan 15, 2020, $*****

Investors

Excelerate Labs & 3 more

Ranked

39^th among 115 active competitors

Employee Count

2 as on Sep 30, 2026

Similar Companies

MiResource & 173 more

View Fibroblast's full profile

Fibroblast is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Fibroblast, Inc. CIN: 45-5385914 , United States, Active	Dec 31, 2010	$1 - $1M (As on Oct 09, 2013)	-	-

Fibroblast has raised a total funding of $3.23M over 4 rounds. Its first funding round was on May 15, 2012. Fibroblast has 4 institutional investors.

Here is the list of recent funding rounds of Fibroblast:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 15, 2020	3636579	Seed	4774594	4978032	1323400	5988001
Jan 15, 2018	8196360	Seed	4340914	7047789	8082467	2121065
Oct 09, 2013	9504894	Seed	6439384	8124441	3477674	8113884

Access funding benchmarks and valuations. Sign up today!

View details of Fibroblast's funding rounds and investors

The founders of Fibroblast are Andrew Albert and Scott Vold.

Here are the details of Fibroblast's key team members:

Andrew Albert: Co-Founder & CMO of Fibroblast.
Scott Vold: Co-Founder & CEO of Fibroblast.

View details of Fibroblast's Founder profiles and Board Members

Fibroblast's employee count trend

Fibroblast has 2 employees as of Sep 26. Here is Fibroblast's employee count trend over the years:

Uncover Fibroblast's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Fibroblast include MiResource, eHealth Technologies and RubiconMD. Here is the list of Top 10 competitors of Fibroblast, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MiResource 2017, Woodside (United States), Seed	Provider of customized mental health treatment solutions and information	$3M	Draper, What If Ventures & 7 others	57/100
2nd	eHealth Technologies 2006, West Henrietta (United States), Series E	Streamlining medical records for better healthcare outcomes and reduced clinician burnout	$55M	Aldrich Capital Partners, Stonehenge Capital ... & 6 others	53/100
3rd	RubiconMD 2013, New York City (United States), Acquired	Virtual specialty care platform connecting primary care with specialist expertise	$37.9M	Waterline Ventures, Deerfield & 19 others	49/100
4th	Refer Well 2015, New York City (United States), Series B	Provider of a cloud-based referral management platform	$11.8M	Connecticut Innovations, Viewside Capital Partners ... & 5 others	47/100
5th	par8o 2011, Newton (United States), Acquired	Patient referral management software	$13.5M	Allscripts, Atlas Venture & 3 others	45/100
6th	LeadingReach 2009, Austin (United States), Unfunded	Referral management and patient engagement platform for the healthcare organizations	-	-	41/100
7th	Clarity Health 2007, Seattle (United States), Acqui-Hired	Care Coordination Service for Healthcare organizations	$13.2M	Columbia Pacific Advisors, Keiretsu Forum ... & 1 others	41/100
8th	Virtual Lucy 2017, Nottingham (United Kingdom), Unfunded	Provider of cloud-based virtual triage appointment booking and referral management solution	-	-	37/100
9th	Valer 2011, Huntington Beach (United States), Unfunded	Provider of prior authorization and referral management solution for healthcare organizations	-	-	37/100
10th	SulAmrica - Todos os direitos reservados 1966, Sao Paulo (Brazil), Funding Raised	Digital patient and hospital networking platform for proffesionals	-	-	36/100
39th	Fibroblast 2011, Chicago (United States), Acqui-Hired	SaaS based referral management system	$3.23M	Excelerate Labs, Techstars & 2 others	25/100